Business Description
Cathay Biotech Inc
ISIN : CNE100004447
Share Class Description:
SHSE:688065: Class ACompare
Compare
Traded in other countries / regions
688065.China IPO Date
2020-08-12Description
Cathay Biotech Inc is engaged in Research, development, production and sales of new bio-based materials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.57 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | 2.73 | |||||
| Interest Coverage | 13.82 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.92 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.6 | |||||
| 3-Year EBITDA Growth Rate | 3.6 | |||||
| 3-Year EPS without NRI Growth Rate | -10.4 | |||||
| 3-Year FCF Growth Rate | -55.5 | |||||
| 3-Year Book Growth Rate | 2.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 45.34 | |||||
| Future 3-5Y Total Revenue Growth Rate | 52.89 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 4.8 | |||||
| 9-Day RSI | 15.86 | |||||
| 14-Day RSI | 26.74 | |||||
| 6-1 Month Momentum % | -3.04 | |||||
| 12-1 Month Momentum % | -17.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.87 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 1.95 | |||||
| Days Inventory | 269.07 | |||||
| Days Sales Outstanding | 38.61 | |||||
| Days Payable | 292.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.46 | |||||
| Dividend Payout Ratio | 0.25 | |||||
| Forward Dividend Yield % | 0.46 | |||||
| 5-Year Yield-on-Cost % | 0.47 | |||||
| Shareholder Yield % | -0.12 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.7 | |||||
| Operating Margin % | 15.66 | |||||
| Net Margin % | 14.39 | |||||
| FCF Margin % | -5.7 | |||||
| ROE % | 3.54 | |||||
| ROA % | 2.14 | |||||
| ROIC % | 3.1 | |||||
| ROC (Joel Greenblatt) % | 4.9 | |||||
| ROCE % | 3.01 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 58.79 | |||||
| Forward PE Ratio | 33.04 | |||||
| PE Ratio without NRI | 52.26 | |||||
| PS Ratio | 8.44 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.18 | |||||
| Price-to-Operating-Cash-Flow | 32.72 | |||||
| EV-to-EBIT | 43.6 | |||||
| EV-to-EBITDA | 43.6 | |||||
| EV-to-Revenue | 7.5 | |||||
| EV-to-FCF | -131.66 | |||||
| Price-to-Projected-FCF | 44.6 | |||||
| Price-to-Graham-Number | 2.23 | |||||
| Earnings Yield (Greenblatt) % | 2.29 | |||||
| FCF Yield % | -0.67 | |||||
| Forward Rate of Return (Yacktman) % | -0.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cathay Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,763.768 | ||
| EPS (TTM) (Â¥) | 0.68 | ||
| Beta | 1.64 | ||
| Volatility % | 48.8 | ||
| 14-Day RSI | 26.74 | ||
| 14-Day ATR (Â¥) | 1.398336 | ||
| 20-Day SMA (Â¥) | 43.7235 | ||
| 12-1 Month Momentum % | -17.58 | ||
| 52-Week Range (Â¥) | 32.48 - 56.98 | ||
| Shares Outstanding (Mil) | 583.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cathay Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cathay Biotech Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cathay Biotech Inc Frequently Asked Questions
What is Cathay Biotech Inc(SHSE:688065)'s stock price today?
The current price of SHSE:688065 is ¥39.69. The 52 week high of SHSE:688065 is ¥56.98 and 52 week low is ¥32.48.
When is next earnings date of Cathay Biotech Inc(SHSE:688065)?
The next earnings date of Cathay Biotech Inc(SHSE:688065) is .
Does Cathay Biotech Inc(SHSE:688065) pay dividends? If so, how much?
The Dividend Yield %  of Cathay Biotech Inc(SHSE:688065) is 0.46% (As of Today), Highest Dividend Payout Ratio of Cathay Biotech Inc(SHSE:688065) was 0.58. The lowest was 0.25. And the median was 0.5. The  Forward Dividend Yield % of Cathay Biotech Inc(SHSE:688065) is 0.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers